BE853215A - Procede de preparation d'isoxazolo /3,4-d/ pyrimidines et leur composition therapeutique - Google Patents

Procede de preparation d'isoxazolo /3,4-d/ pyrimidines et leur composition therapeutique

Info

Publication number
BE853215A
BE853215A BE176398A BE176398A BE853215A BE 853215 A BE853215 A BE 853215A BE 176398 A BE176398 A BE 176398A BE 176398 A BE176398 A BE 176398A BE 853215 A BE853215 A BE 853215A
Authority
BE
Belgium
Prior art keywords
isoxazolo
pyrimidines
preparation
therapeutic composition
therapeutic
Prior art date
Application number
BE176398A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BE853215A publication Critical patent/BE853215A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE176398A 1976-04-05 1977-04-04 Procede de preparation d'isoxazolo /3,4-d/ pyrimidines et leur composition therapeutique BE853215A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51038419A JPS6029398B2 (ja) 1976-04-05 1976-04-05 イソオキサゾロ〔３，４−ｄ〕ピリミジン誘導体

Publications (1)

Publication Number Publication Date
BE853215A true BE853215A (fr) 1977-10-04

Family

ID=12524781

Family Applications (1)

Application Number Title Priority Date Filing Date
BE176398A BE853215A (fr) 1976-04-05 1977-04-04 Procede de preparation d'isoxazolo /3,4-d/ pyrimidines et leur composition therapeutique

Country Status (12)

Country Link
US (1) US4129654A (fr)
JP (1) JPS6029398B2 (fr)
AU (1) AU507964B2 (fr)
BE (1) BE853215A (fr)
CA (1) CA1082701A (fr)
CH (1) CH631715A5 (fr)
DE (1) DE2714253A1 (fr)
DK (1) DK148577A (fr)
FR (1) FR2375237A1 (fr)
GB (1) GB1547053A (fr)
NL (1) NL7703676A (fr)
SE (1) SE7703284L (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152890A (ja) * 1982-03-08 1983-09-10 Takeda Chem Ind Ltd イソキサゾロピリミジン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517008A (en) * 1968-04-05 1970-06-23 American Home Prod 1-alkyl-6-substituted isoxazolo(3,4-d)pyrimidin-3(1h)-ones
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
BE790010A (fr) * 1971-10-15 1973-04-12 Fmc Corp Herbicides nouveaux
BE790008A (fr) * 1971-10-15 1973-04-12 Fmc Corp Nouveaux composes herbicides
US3778438A (en) * 1972-05-30 1973-12-11 Sandoz Ag 4-amino-isoxazolo(5,4-d)pyrimidines and nitrates thereof

Also Published As

Publication number Publication date
CA1082701A (fr) 1980-07-29
FR2375237A1 (fr) 1978-07-21
FR2375237B1 (fr) 1981-06-19
DE2714253A1 (de) 1977-10-27
US4129654A (en) 1978-12-12
AU507964B2 (en) 1980-03-06
GB1547053A (en) 1979-06-06
CH631715A5 (de) 1982-08-31
SE7703284L (sv) 1977-10-06
AU2397777A (en) 1978-10-12
JPS52139091A (en) 1977-11-19
NL7703676A (nl) 1977-10-07
DK148577A (da) 1977-10-06
JPS6029398B2 (ja) 1985-07-10

Similar Documents

Publication Publication Date Title
BE891094Q (fr) N-benzoyl-n'-pyridyloxy-phenylurees et leur procede de preparation
BE878723A (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
FR2449699B1 (fr) Polyetherpolyamides et leur procede de preparation
BE866841A (fr) Procede de preparation d'imidazoazines et -diazines substituees et leur utilisation
FR2343748A1 (fr) Derives de 2,3-dihydro imidazo (2,1-b) thiazole, leur procede de preparation et leur application en therapeutique
BE866031A (fr) Nouveaux 2-(2,2-diarylalkyl)-1-azabicyclo (2,2,2)octanes, utiles notamment comme antidiarrheiques, et leur procede de preparation
BE854268A (fr) Pyrrolidones, leur procede de preparation et leur application therapeutique
FR2458547B2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
BE862785A (fr) Derives de pyrimido(6,1-a)isoquinoleine-2-one, leur procede de preparation et leur application en therapeutique
PT73988B (fr) Procede de preparation de derives de la thieno-pyridinone et leur application therapeutique
BE881752A (fr) Nouveaux derives hydroxyles de la pyrimidine, leur preparation et leur utilisation therapeutique
BE858356A (fr) Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique
BE850702A (fr) Procede de preparation de copolymeres biologiquement actifs
BE854133A (fr) 1,3-dihydro-heteroarylspito(isobenzofurannes)et leur procede de preparation et leur application therapeutique
BE826928A (fr) Pyrrolo (3,4-d) pyrimidines et leur procede de preparation
FR2305416A1 (fr) Procede de preparation de tricosene-(9) et d'heneicosene-(9)
BE854812A (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
BE872294A (fr) Procede de preparation de 3-iodorifamycine s et de 3-bromorifamycine s
BE884652R (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
FR2353556A1 (fr) Derives de l'acide clavulanique, leur procede de preparation et leur application en therapeutique
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
FR2346337A1 (fr) Derives d'uracil, leur procede de preparation et leur application pharmacologique
BE853739A (fr) Composition d'amino-alcools et leur procede de preparation
BE853215A (fr) Procede de preparation d'isoxazolo /3,4-d/ pyrimidines et leur composition therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES LTD

Effective date: 19840404